Early Glycoprotein IIb/IIIa Inhibition in Non–ST-Segment Elevation Acute Coronary Syndromes - EARLY ACS

Description:

The goal of the trial was to evaluate the upstream use of the glycoprotein (GP) IIb/IIIa inhibitor eptifibatide compared with provisional eptifibatide administration in the catheterization laboratory in patients with non–ST-elevation acute coronary syndrome (NSTE ACS).